During scar formation, STC-1 modulates fibroblast activity, immune responses, angiogenesis, and ECM remodeling through coordinated regulation of multiple signaling pathways. Collectively, these effects may contribute to STC-1's ability to improve the quality of tissue repair and scar remodeling in vivo. The PI3K/AKT pathway represents one downstream pathway associated with STC-1 activity. However, its efficacy in treating established pathological scars, including keloids, remains to be validated in future studies using more clinically relevant models.
Lin et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: